How the Novavax Coronavirus Vaccine Uses Moth Cells
As companies like Moderna and Pfizer race to use cutting-edge mRNA technology to deliver the first set of coronavirus vaccines, Novavax took a different approach. The Maryland biotechnology company used insect cells to produce the coronavirus’s unique spiked protein, which can then be introduced to patients to prime their immune systems. This process is known as a recombinant protein vaccination.
April 1, 2023 | Source: The Vaccine Reaction | by The Washington Post
As companies like Moderna and Pfizer race to use cutting-edge mRNA technology to deliver the first set of coronavirus vaccines, Novavax took a different approach. The Maryland biotechnology company used insect cells to produce the coronavirus’s unique spiked protein, which can then be introduced to patients to prime their immune systems. This process is known as a recombinant protein vaccination.